Eric Schmidt - Insider Trading & Ownership

Location
C/O Allogene Therapeutics, Inc., 210 East Grand Avenue, South San Francisco, CA
Summary
The estimated net worth of Eric Schmidt is at least $11.1M dollars as of June 12, 2023. Eric Schmidt is the Chief Financial Officer of Allogene Therapeutics, Inc. and owns shares of Allogene Therapeutics, Inc. (ALLO) stock worth about $10.6M. Eric Schmidt is the Director of Revolution Medicines, Inc. and owns shares of Revolution Medicines, Inc. (RVMD) stock worth about $574K.
Signature
/s/ Jack Anders, as Attorney-in-fact for Eric Schmidt
All Insider Reports
All Insider Reports

Ownership of Eric Schmidt

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ALLO Allogene Therapeutics, Inc. Chief Financial Officer $10.6M Mar 22, 2023
RVMD, RVMDW Revolution Medicines, Inc. Director $574K Jun 8, 2023
RLMD RELMADA THERAPEUTICS, INC. Director May 25, 2023

Insider Transactions Reported by Eric Schmidt:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.